Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
M Ebrahimi, SA Seyedi, SA Nabipoorashrafi… - Lipids in Health and …, 2023 - Springer
Background Lipid accumulation product (LAP) is an index calculated by waist circumference
(WC) and triglyceride (TG), which reflects lipid toxicity. This study aims to investigate the …
(WC) and triglyceride (TG), which reflects lipid toxicity. This study aims to investigate the …
Potential of Chlorella as a Dietary Supplement to Promote Human Health
T Bito, E Okumura, M Fujishima, F Watanabe - Nutrients, 2020 - mdpi.com
Chlorella is a green unicellular alga that is commercially produced and distributed
worldwide as a dietary supplement. Chlorella products contain numerous nutrients and …
worldwide as a dietary supplement. Chlorella products contain numerous nutrients and …
American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with …
WT Garvey, JI Mechanick, EM Brett, AJ Garber… - Endocrine Practice, 2016 - Elsevier
Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …
Clinical Endocrinologists (AACE) Board of Directors and the American College of …
Fatty acids consumption: the role metabolic aspects involved in obesity and its associated disorders
P Silva Figueiredo, A Carla Inada, G Marcelino… - Nutrients, 2017 - mdpi.com
Obesity and its associated disorders, such as insulin resistance, dyslipidemia, metabolic
inflammation, dysbiosis, and non-alcoholic hepatic steatosis, are involved in several …
inflammation, dysbiosis, and non-alcoholic hepatic steatosis, are involved in several …
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Background Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder
worldwide, reaching prevalence up to 90% in obese patients with type 2 diabetes (T2D), and …
worldwide, reaching prevalence up to 90% in obese patients with type 2 diabetes (T2D), and …
Pathophysiology of NAFLD and NASH in experimental models: the role of food intake regulating peptides
L Kořínková, V Pražienková, L Černá… - Frontiers in …, 2020 - frontiersin.org
Obesity, diabetes, insulin resistance, sedentary lifestyle, and Western diet are the key factors
underlying non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases …
underlying non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases …
[HTML][HTML] Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
C Gelli, M Tarocchi, L Abenavoli… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To determine the clinical effectiveness of nutritional counseling on reduction of non-
alcoholic fatty liver disease (NAFLD) severity, weight loss, metabolic and anthropometric …
alcoholic fatty liver disease (NAFLD) severity, weight loss, metabolic and anthropometric …
Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality
IN BRIEF Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized and
common cause of chronic liver disease worldwide. Although most patients with NAFLD are …
common cause of chronic liver disease worldwide. Although most patients with NAFLD are …
Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease
X Shen, H Guo, J Xu, J Wang - Journal of Cellular Physiology, 2019 - Wiley Online Library
This study is conducted to investigate the role of long noncoding RNA highly upregulated in
liver cancer (lncRNA HULC) on hepatic fibrosis and hepatocyte apoptosis by inhibiting the …
liver cancer (lncRNA HULC) on hepatic fibrosis and hepatocyte apoptosis by inhibiting the …
The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double …
M Jarhahzadeh, P Alavinejad, F Farsi, D Husain… - Diabetology & metabolic …, 2021 - Springer
Background Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of
liver transaminases elevation and a global health concern. Purpose This study designed to …
liver transaminases elevation and a global health concern. Purpose This study designed to …